Drug Profile
Research programme: anticancer protease inhibitors - Curacyte
Alternative Names: CJ-463 uPA inhibitor; CJ-730 matriptase inhibitor; Matriptase inhibitors - Curacyte; Urokinase plasminogen activator inhibitors - CuracyteLatest Information Update: 03 Aug 2007
Price :
$50
*
At a glance
- Originator Curacyte AG
- Class Small molecules
- Mechanism of Action Hepatocyte growth factor inhibitors; Matriptase inhibitors; Peptide hydrolase inhibitors; Urokinase-type plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 18 Oct 2005 Preclinical trials in Cancer in Germany (unspecified route)